Research Article
Fetal and Maternal Outcomes of Planned Pregnancy in Patients with Systemic Lupus Erythematosus: A Retrospective Multicenter Study
Table 5
Univariate analysis of variables associated with adverse maternal outcomes.
| Characteristics | PIH | Yes () | No () | value |
| Disease flares during pregnancy | 22(75.9) | 30(14.0) | <0.001 | Active lupus nephritis | 18(62.1) | 27(12.6) | <0.001 | Thrombocytopenia | 9(31.0) | 14(6.5) | <0.001 | Leukopenia | 3(10.3) | 4(1.9) | 0.04 | Anti-dsDNA antibody positivity | 12(41.4) | 81(37.9) | 0.7 | Anti-Ro antibody positivity | 14(48.3) | 85(39.7) | 0.4 | Anti-La antibody positivity | 2(6.9) | 31(14.5) | 0.4 | LAC positivity | 7(24.1) | 12(5.6) | 0.003 | Anticardiolipin antibody positivity | 15(51.7) | 14(6.5) | <0.001 | Anti-beta2 GP1 positivity | 1(3.4) | 20(9.3) | 0.5 | Hypoalbuminemia | 11(37.9) | 55(25.7) | 0.2 | Hypocomplementemia | 14(48.3) | 42(19.6) | 0.001 | Hydroxychloroquine | 13(44.8) | 113(52.8) | 0.4 |
|
|